Metoxfenidina

Methoxphenidine (also known as 2-MXP or MXP) is a lesser-known novel dissociative substance of the diarylethylamine class. It is an NMDA antagonist with subjective effects similar to those of ketamine and phencyclidine (PCP). It is structurally related to diphenidine and ephenidine.

Also known as: Mxp, 2-mxp, Methoxyphenidine, 2-meo-diphenidine, 2-Methoxydiphenidine

Classification

Chemical: Arylcyclohexylamine
Chemical: Diarylethylamine
Psychoactive: Dissociative
Tag: Habit-Forming
Tag: Research-Chemical
Tag: Tentative

Effects

Physical Euphoria
Spontaneous Tactile Sensations
Tactile Disconnection
Sedation
Incoordination
Impaired Balance
Amnesia
Anxiety Suppression
Cognitive Euphoria
Conceptual Thinking
Consciousness Disconnection
Depersonalization
Acuity Suppression
Auditory Distortion
Auditory Hallucination
Auditory Suppression
Autonomous Entity
Disinhibition

Routes of Administration

Oral

Dosage

Common: 75-120 mg
Light: 50-75 mg
Strong: 120-150 mg
Threshold: 30-50 mg
Heavy: 150–200 mg

Duration

Onset: 0.5-1 h
After Effects: 6-12 h
Peak: 2-3 h
Offset: 3-5 h
Total Duration: 4-7 h

Intravenous

Dosage

Heavy: 60+ mg
Light: 10–20 mg
Common: 20–40 mg
Strong: 40–60 mg
Threshold: 5 mg

Duration

Onset: 0.03-0.1 h
Peak: 0.2-1 h
Offset: 2-4 h
After Effects: 4-10 h
Total Duration: 3-6 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu